• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Recruiting Phone Calls Are Legal, FCC Clarifies

Recruiting Phone Calls Are Legal, FCC Clarifies

February 1, 2021

Calls made to a residential phone line for the purpose of seeking an individual’s participation in a clinical trial are exempt from the Telephone Consumer Protection Act (TCPA) restricting prerecorded calls, the Federal Communications Commission (FCC) says.

In a declaratory ruling issued on Jan. 15, the FCC’s Consumer and Governmental Affairs Bureau agreed with Acurian, a research organization that matches eligible people for trials, that such calls should be exempt from the TCPA because they were not made for a commercial purpose. Acurian filed a petition with the FCC in 2014.

The declaratory ruling indicated that the FCC was moved by the argument that drugs involved in trials have typically not received FDA approval and therefore are not products that can legally be marketed or sold and as such cannot be a “product or service” typically sold by telemarketers. The FCC also said it recognized the importance of trials, especially during the pandemic, adding that some consumers may welcome calls to participate in trials.

The FCC’s clarification took immediate effect.

Read the FCC’s declaratory ruling here: https://bit.ly/39o8eNm.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • tablet

    Digital Intake Platforms Effective as Source of Trial Information, Survey Shows

  • Diversity-360x240.png

    Site Spotlight: EmVenio Research Takes to the Road to Promote Trial Diversity

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing